Ashcombe Advisers advised on the recent investment by Synova Capital in Kinapse, the leading provider of outsourced services to the global life sciences industry with a particular focus on the areas of regulatory and compliance services.
Kinapse counts 7 of the top 10 global life sciences companies as customers and regulatory organisations such as the European Medicines Agency. Kinapse operates a unique blended resourcing model enabling the Business to offer customers cost effective offshore solutions allied to input from industry-leading professionals based in the UK. The Group has offices in the UK, India and the United States.